Merck Provides Update on REVEAL Outcomes Study of Anacetrapib

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/27/2026

1. INTC
2. DECK
3. META
4. AMD
5. GOOGL
6. INFY
7. SPY
8. TMUS
9. UNP
10. NVDA

Go back to Merck Provides Update on REVEAL Outcomes Study of Anacetrapib
Merck & Co. (NYSE: MRK) Delayed: 131.07 --0 (-0%)
Previous Close $131.07    52 Week High $65.46 
Open $131.07    52 Week Low $47.97 
Day High $131.07    P/E 89.16 
Day Low $131.07    EPS $1.47 
Volume 814